Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

In conjunction with media coverage of the recently published Cochrane review, and interviews with SPCR researcher Professor Carl Heneghan from the University of Oxford, a review of observational studies of Oseltamivir was published this week by researchers at the University of Birmingham and UCL.

Tamiflu investigations

SPCR researcher Professor Melanie Calvert and SPCR doctoral student Derek Kyte (University of Birmingham) have had a rapid review published in the BMJ this week, in collaboration with colleagues at UCL. The BMJ invited the group to undertake a review of observational studies investigating the influenza drug Oseltamivir (Tamiflu), to coincide with the publication of an updated systematic review by the Cochrane group that has received a lot of media attention for casting doubt over the efficacy of the antiviral drug, stockpiled in huge quantities in the UK. 

READ MORE about the Cochrane review on the Centre for Evidence Based Medicine (CEBM) website, and listen to BBC media coverage.